Browse the evidence

Healthful diets are based primarily on fruits, vegetables, and grains, with smaller quantities of meat and dairy foods.

Practitioners should emphasize the inclusion of fruits, vegetables, and grains in dietary recommendations.

Healthful diets provide adequate amounts of energy and essential nutrients.

Dietary guidelines should ensure that diets are adequate in energy and essential nutrients.

Healthful diets reduce risks for diet-related chronic diseases.

Encouraging healthful diets can be a strategy to prevent chronic diseases.

A 12-week partial meal replacement (PMR) diet is effective for weight loss in overweight or obese patients after ischemic stroke, with 52.9% of participants achieving ≥5% weight loss compared to 11.9% in the standard care group.

Healthcare providers can consider PMR diets as a viable option for weight management in stroke patients.

The study lasted for 12 months with follow-up weight measurements at multiple time points.

This indicates the study's comprehensive approach to measuring weight loss over time.

Behavioral treatment for obesity includes components such as self-monitoring, functional analyses, stimulus control, cognitive restructuring, problem-solving, and relapse prevention.

Practitioners should incorporate these components into obesity treatment programs.

Weight loss requires the induction of a negative energy balance.

Weight loss strategies should focus on creating a negative energy balance.

Patient-delivered lifestyle intervention yielded significantly less weight regain than standard-of-care (SOC) at month 18 (0.77 kg vs 2.37 kg; P = .002).

Patient-delivered interventions may be a viable alternative for weight loss maintenance.

Patient-delivered intervention showed parallel improvements in diastolic blood pressure, heart rate, physical activity, and sedentary behavior compared to SOC.

Improving cardiovascular metrics can enhance overall health in weight maintenance programs.

During peak week, frequency, volume, and intensity of resistance training decreased while repetition ranges of compound exercises increased.

Competitors should focus on adjusting their training load to reduce stress while increasing repetitions for compound movements.

Each 100 MET-min/wk increase in accelerometry-measured moderate-to-vigorous physical activity (MVPA) from baseline to 4 years is associated with decreased risk of cardiovascular disease (CVD) outcomes.

Encouraging long-term engagement in MVPA can help reduce CVD risk in this population.

Increased accelerometry-measured MVPA from baseline to year 4 is associated with decreased risk of CVD outcomes.

Long-term engagement in MVPA is crucial for reducing CVD risk in this demographic.

Adults generally need no more than 0.8–0.9 g/kg/d of protein to meet their needs.

Adults should aim for a protein intake within this range to meet their nutritional needs.

Subjects in the weight loss program reduced their weight by 6.2% ±2.1%.

Practitioners can expect significant weight loss in participants following a structured diet and exercise program.

The combined compliance rate for the diet and exercise program averaged 92.9%.

A high combined compliance rate suggests that the program was well-received and effective.

Weight loss is the primary determinant of risk reduction in lifestyle programs to prevent diabetes.

Practitioners should prioritize weight loss strategies in diabetes prevention programs.

Hunger was the only significant predictor of weight change in a multivariate model including craving-trait and eating behaviors.

Addressing hunger may be more effective than focusing solely on cravings in weight loss strategies.

Among individuals with central adiposity, replacing SSB with either ASB or USB had a favorable effect on body weight.

Practitioners may consider recommending ASB or USB for weight management in individuals with central adiposity.

Semaglutide led to a mean relative weight loss of 13.3 ± 11.3% after 12 months in adults with type 1 diabetes.

Practitioners can consider semaglutide as an effective option for weight management in overweight/obese patients with type 1 diabetes.

Initiation of semaglutide was significantly associated with a -3.8% reduction in weight at 13 to 24 months.

Semaglutide may be an effective option for weight management in adults.

The appropriate use of NB-ER should consider the specific characteristics and adiposity-related complications of an individual.

Practitioners should assess individual patient characteristics when prescribing NB-ER.

Tirzepatide has been approved by the FDA for treating T2D and managing chronic weight in overweight or obese patients.

Healthcare providers can confidently prescribe tirzepatide for eligible patients based on FDA approval.

Protein sources and physical activity were positively associated with lean mass in males and/or females.

Encouraging high-quality protein sources and physical activity is beneficial for maintaining lean mass in both sexes.

Current guidelines recommend a healthier lifestyle for all CV risk categories.

Healthcare providers should promote lifestyle changes as a preventive measure for cardiovascular disease.